Clinical trial

Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With…

NCT00063622 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed

Key facts

NCT number NCT00063622
Title Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Official title Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Acronym PIVENS
Lead sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Liver Diseases
Intervention type Dietary Supplement, Drug
Interventions Pioglitazone, Vitamin E, Matching placebo
Enrollment 247
Start date Jan 1, 2005
Primary completion Jun 1, 2009
Completion Sep 1, 2009
First posted Jul 3, 2003
Last update posted Apr 6, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies